A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses

Due to the recrudescence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections worldwide, mainly caused by the Omicron variant of concern (VOC) and its sub-lineages, several jurisdictions are administering an mRNA vaccine boost. Here, we analyze humoral responses induced after t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tauzin, Alexandra, Gong, Shang Yu, Chatterjee, Debashree, Ding, Shilei, Painter, Mark M., Goel, Rishi R., Beaudoin-Bussières, Guillaume, Marchitto, Lorie, Boutin, Marianne, Laumaea, Annemarie, Okeny, James, Gendron-Lepage, Gabrielle, Bourassa, Catherine, Medjahed, Halima, Goyette, Guillaume, Williams, Justine C., Bo, Yuxia, Gokool, Laurie, Morrisseau, Chantal, Arlotto, Pascale, Bazin, Renée, Fafard, Judith, Tremblay, Cécile, Kaufmann, Daniel E., De Serres, Gaston, Richard, Jonathan, Côté, Marceline, Duerr, Ralf, Martel-Laferrière, Valérie, Greenplate, Allison R., Wherry, E. John, Finzi, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533674/
https://www.ncbi.nlm.nih.gov/pubmed/36244343
http://dx.doi.org/10.1016/j.celrep.2022.111554

Ejemplares similares

Ejemplares similares